相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
F. J. Giles et al.
LEUKEMIA (2013)
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
Hagop Kantarjian et al.
BLOOD (2012)
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
H. J. Khoury et al.
BONE MARROW TRANSPLANTATION (2012)
Management of Chronic Myeloid Leukemia in Childhood
Meinolf Suttorp et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2012)
Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
Anthony Oyekunle et al.
ACTA HAEMATOLOGICA (2011)
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase
Qian Jiang et al.
BLOOD (2011)
Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)
Evgeny Klyuchnikov et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
Susanne Saussele et al.
BLOOD (2010)
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
Meinolf Suttorp et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?
O. Krieger
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2010)
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia-a report from the German Registry covering the period from 1998 to 2004
Ulrike Bacher et al.
ANNALS OF HEMATOLOGY (2009)
Current role of stem cell transplantation in chronic myeloid leukaemia
Alois Gratwohl et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
Michele Baccarani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors
Jorge Cortes et al.
BLOOD (2007)
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia - No evidence for increased transplant-related toxicity
Elias Jabbour et al.
CANCER (2007)
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia
Sergio A. Giralt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
EBMT activity survey 2004 and changes in disease indication over the past 15 years
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2006)
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
C Crawley et al.
BLOOD (2005)
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: A study by the GIMEMA working party on chronic myeloid leukemia
S Soverini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML
FR Kerbauy et al.
LEUKEMIA (2005)
Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction
M Alizadeh et al.
BLOOD (2002)
Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation
B Fehse et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants
D Gaziev et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
